OKCLEAR SCIENCE

OKCLEAR Science: IgY & Fel d 1

Learn how OKCLEAR approaches cat allergen management with egg-yolk IgY targeting Fel d 1, alongside broader Fel d 2–8 research.

OKCLEAR Science: IgY & Fel d 1

ON THIS PAGE

Fel d 1–8 describes the R&D direction and does not prove full-target efficacy. Results for other products in published papers are not results for this product.

FEL D 1

What Fel d 1 is

Fel d 1 is present in cat saliva and skin secretions. Grooming moves it onto the coat, and dander and dust then carry it around the home. Hair itself is usually not the allergen; it is the carrier.

Fel d 1–8 at a glance
Fel d 1SecretoglobinAssociated with salivary and sebaceous glands; the core component in cat allergy research
Fel d 2Serum albuminCarries cross-species cross-reactivity significance; an important complement in component diagnostics
Fel d 3CystatinA supplementary component in the cat allergen profile, reflecting individual sensitization differences
Fel d 4LipocalinMainly saliva-associated; can contribute to component sensitization in some people
Fel d 5Immunoglobulin-relatedBroadens cat allergen identification beyond a single Fel d 1 pathway
Fel d 6Immunoglobulin-relatedUsed to build a more complete multi-component research and testing framework
Fel d 7LipocalinRelated to part of the respiratory sensitization profile; a focus of the broad-spectrum strategy
Fel d 8Latherin-like proteinCompletes multi-target coverage of the Fel d allergen family

IGY

Why egg-yolk IgY

IgY is an egg-yolk antibody. Published laboratory studies show anti-Fel d 1 IgY can bind the protein and reduce measured active Fel d 1. This source-side approach intervenes before allergens enter the environment.

FEL D 1–8 FRAMEWORK

The Fel d 1–8 R&D and testing framework

Fel d 1 is one of the better-studied components, but cat allergy is not decided by one component alone; Fel d 2, 4 and 7 also contribute to different molecular sensitization profiles. A multi-target framework does not mean every home must handle eight components at once; it means R&D should not reduce real exposure to a single marker.

PATENT POSTURE

Intellectual-property posture

Core formulations and preparation processes are the subject of patent filings around Fel d1–8, covering broad-spectrum IgY antibody preparation, product formulations and application methods. Status follows verifiable filing or grant information; an application is not a granted patent.

SOURCE → COAT → HOME

The source–coat–home pathway

Three stages map to three product touchpoints: daily nutrition at the source, grooming and wiping on the coat, spray and litter in the shared home.

The cat's mouth

01

The cat's mouth

Management begins at the source of saliva-associated allergens, through the daily feeding route.

Coat and dander

02

Coat and dander

After grooming, microscopic particles can travel with the coat and dander.

Shared living space

03

Shared living space

Bedding, sofas, clothing and litter areas form the high-frequency contact points at home.

PUBLISHED RESEARCH

A continuously updated scientific library

105cats

IID · 2019

Active Fel d 1 on the coat

Significant reduction from week 3; an average reduction of about 47% later in the study

Read original paper ↗

26weeks

Frontiers · 2020

Adult cat safety

No ingredient-related adverse effects observed under the test conditions

Read original paper ↗

84days

Frontiers · 2024

Kitten safety

27 kittens in a randomized blinded controlled study; no biologically meaningful adverse changes

Read original paper ↗

42people

MASK-air · 2024

Human home observation

After one month, overall, nasal, ocular and symptom–medication scores all showed improvement

Read original paper ↗

GLOBAL PARTNERSHIPS

Building the cat-allergen management category with professional partners

We look for partners who can turn technical evidence into compliant market education, channel execution and ongoing customer support. Scope is assessed project by project.